Nevertheless, as the causes of the reduced responsiveness to insulin are numerous and multifactorial, deciphering the complexity of the insulin resistance pathogenesis remains one of the great challenges on the way toward developing new molecules for a more effective treatment of T2D and associated diseases. The gene discussed is INS; the disease is type 2 diabetes mellitus.